logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • N-methyl-D-aspartate Receptor Antagonist class drugs

    FiltersReset Filters
    7 results

    • memantine

      (Memantine)
      Dr. Reddys Laboratories Limited
      Usage: Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia associated with Alzheimer's disease.

    • memantine hydrochloride

      (memantine)
      Amneal Pharmaceuticals LLC
      Usage: Memantine hydrochloride tablets are indicated for treating moderate to severe Alzheimer's disease dementia.

    • memantine hydrochloride

      (memantine hydrochloride)
      Slate Run Pharmaceuticals, LLC
      Usage: Memantine Hydrochloride Extended-Release Capsules are indicated for treating moderate to severe dementia associated with Alzheimer's disease.

    • memantine hydrochloride

      (Memantine Hydrochloride)
      Upsher-Smith Laboratories, LLC
      Usage: Memantine hydrochloride tablets are indicated for the treatment of moderate to severe Alzheimer's disease-related dementia.

    • memantine hydrochloride

      (Memantine Hydrochloride)
      Ajanta Pharma USA Inc.
      Usage: Memantine hydrochloride is indicated for treating moderate to severe dementia associated with Alzheimer's disease.

    • memantine hydrochloride

      (Memantine hydrochloride)
      Lupin Pharmaceuticals, Inc.
      Usage: Memantine hydrochloride is indicated for the treatment of moderate to severe Alzheimer's-type dementia.

    • namzaric

      (memantine hydrochloride and donepezil hydrochloride)
      Allergan, Inc.
      Usage: NAMZARIC is indicated for treating moderate to severe Alzheimer's-type dementia in patients who are stabilized on a daily dose of 10 mg of donepezil hydrochloride.